LABHARDT

Labhardt is a distributor of medical devices.

#SimilarOrganizations #More

LABHARDT

Industry:
Health Care Medical Device

Address:
Basel, Basel-Stadt, Switzerland

Country:
Switzerland

Status:
Active


Similar Organizations

leeper-brothers-logo

Leeper Brothers

Leeper Brothers, a distributor of medical gases.

medicor-logo

Medicor

Medicor is a distributor of medical devices.

ortopro-logo

Ortopro

Ortopro is distributes orthopedic devices.

More informations about "Labhardt"

Prof Niklaus Labhardt - BRCCH

Prof Niklaus Labhardt is the division head of Clinical Epidemiology at the University of Basel. He is a physician trained in Switzerland, Cameroon and Lesotho specializing in infectious diseases and tropical medicine with a …See details»

Research group Labhardt, N. | Department of Clinical …

Niklaus Labhardt is a physician certified in Infectious Diseases, Tropical Medicine, and Internal Medicine. He holds a Master in International Health from the Swiss Tropical and Public Health Institute and obtained an assistant professorship …See details»

Labhardt | Clinical Epidemiology | University of Basel

Niklaus Labhardt is a physician certified in Infectious Diseases, Tropical Medicine, and Internal Medicine. He holds a Master in International Health from the Swiss Tropical and Public Health Institute and obtained an assistant professorship …See details»

Niklaus LABHARDT | Division Head | Professor - ResearchGate

Niklaus Labhardt is an Infectious Diseases physician with a Master in International Health. He heads the Division of Clinical Epidemiology at the Department of Clinical Research at the …See details»

Niklaus Labhardt to become professor of clinical epidemiology

See details»

Improving HIV treatment for children and adolescents

Jul 18, 2024 · Researchers led by Professor Niklaus Labhardt at the University of Basel and University Hospital Basel have therefore got together with various international partners to investigate whether these cost- and labor-intensive …See details»

‪Niklaus Labhardt‬ - ‪Google Scholar‬

How to bring research evidence into policy? Synthesizing strategies of five research projects in low-and middle-income countries. S Erismann, MA Pesantes, D Beran, A Leuenberger, A …See details»

Niklaus Daniel Labhardt's lab | University of Basel (UNIBAS)

Niklaus Labhardt is an Infectious Diseases physician with a Master in International Health. He heads the Division of Clinical Epidemiology at the Department of Clinical Research at the …See details»

Effect of Offering Same-Day ART vs Usual Health Facility Referral ...

Mar 3, 2018 · Does offering antiretroviral therapy (ART) to sub-Saharan African residents the same day they tested positive for HIV in a home-based testing program improve linkage to …See details»

Improving HIV treatment in children and adolescents -- the right …

Jul 18, 2024 · Researchers led by Professor Niklaus Labhardt at the University of Basel and University Hospital Basel have therefore got together with various international partners to …See details»

Should viral load thresholds be lowered?: Revisiting the WHO

The World Health Organization (WHO) guidelines on antiretroviral therapy (ART) define treatment failure as 2 consecutive viral loads (VLs) ≥1000 copies/mL. There is, however, little evidence …See details»

Community-based type 2 diabetes care by lay village health …

Oct 24, 2023 · Task-shifting to lay village health workers (VHWs) and the use of digital clinical decision support systems (CDSS) are promising approaches to tackle the current T2D care …See details»

Metabolic syndrome in patients on first‐line antiretroviral therapy ...

Mar 25, 2017 · To assess the prevalence of metabolic syndrome (MetS) among patients in rural Lesotho who are taking first-line antiretroviral therapy (ART) containing either zidovudine or …See details»

When patients fail UNAIDS’ last 90 - Wiley Online Library

Jul 19, 2017 · Conclusions: In this study in rural Lesotho, outcomes along the “failure cascade” were poor. To improve outcomes in this vulnerable patient group who fails the last “90”, …See details»

Is zidovudine first‐line therapy virologically comparable to …

Mar 17, 2015 · The majority of patients enrolled in the study had no clinical or immunological failure, according to the World Health Organization 1 definition. We found that among patients …See details»

Home-Based Versus Mobile Clinic HIV Testing and Counseling in

Dec 16, 2014 · Niklaus Labhardt and colleagues investigate how different HIV testing and counseling strategies, based on home visits or mobile clinics, reach different populations in a …See details»

Effect of Offering Same-Day ART vs Usual Health Facility ... - PubMed

Mar 20, 2018 · Objective: To determine whether offering same-day home-based ART to patients with HIV improves linkage to care and viral suppression in a rural, high-prevalence setting in …See details»

Emergence of acquired dolutegravir resistance in treatment …

Apr 4, 2024 · Background: Since 2019, the World Health Organization has recommended dolutegravir-based antiretroviral therapy (ART) as the preferred regimen for HIV management. …See details»

Effect of Offering Same-Day ART vs Usual Health Facility Referral ...

Dr Labhardt reported having received support from the Stiftung für Infektiologie beider Basel and the Gottfried and Julia Bangerter-Rhyner Foundation and travel support to medical …See details»

Improved retention rates with low‐cost interventions in …

Jul 6, 2011 · In a primary healthcare programme in eight Cameroon districts, where the task to care for hypertensive patients and patients with diabetes has been shifted to nurse-led …See details»

linkstock.net © 2022. All rights reserved